Global Hereditary Angioedema Sales Market Report 2021
Report Code: KNJ921019
Publisher: Date of Publish:
No. of Pages: 118 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
The global Hereditary Angioedema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type C1 Esterase Inhibitor Kallikrein Inhibitor Selective Bradykinin B2 Receptor Antagonist Segment by Application Retail Pharmacies Hospital Pharmacies Online Pharmacies The Hereditary Angioedema market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereditary Angioedema market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Pharming Group NV Takeda CSL Limited iBio Inc. BioCryst Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc.
1 Hereditary Angioedema Market Overview 1.1 Hereditary Angioedema Product Scope 1.2 Hereditary Angioedema Segment by Type 1.2.1 Global Hereditary Angioedema Sales by Type (2016 & 2021 & 2027) 1.2.2 C1 Esterase Inhibitor 1.2.3 Kallikrein Inhibitor 1.2.4 Selective Bradykinin B2 Receptor Antagonist 1.3 Hereditary Angioedema Segment by Application 1.3.1 Global Hereditary Angioedema Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Online Pharmacies 1.4 Hereditary Angioedema Market Estimates and Forecasts (2016-2027) 1.4.1 Global Hereditary Angioedema Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Hereditary Angioedema Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Hereditary Angioedema Price Trends (2016-2027) 2 Hereditary Angioedema Estimates and Forecasts by Region 2.1 Global Hereditary Angioedema Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Hereditary Angioedema Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Hereditary Angioedema Sales Market Share by Region (2016-2021) 2.2.2 Global Hereditary Angioedema Revenue Market Share by Region (2016-2021) 2.3 Global Hereditary Angioedema Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Hereditary Angioedema Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Hereditary Angioedema Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Hereditary Angioedema Estimates and Projections (2016-2027) 2.4.2 Europe Hereditary Angioedema Estimates and Projections (2016-2027) 2.4.3 China Hereditary Angioedema Estimates and Projections (2016-2027) 2.4.4 Japan Hereditary Angioedema Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Hereditary Angioedema Estimates and Projections (2016-2027) 2.4.6 India Hereditary Angioedema Estimates and Projections (2016-2027) 3 Global Hereditary Angioedema Competition Landscape by Players 3.1 Global Top Hereditary Angioedema Players by Sales (2016-2021) 3.2 Global Top Hereditary Angioedema Players by Revenue (2016-2021) 3.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2020) 3.4 Global Hereditary Angioedema Average Price by Company (2016-2021) 3.5 Manufacturers Hereditary Angioedema Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Hereditary Angioedema Market Size by Type 4.1 Global Hereditary Angioedema Historic Market Review by Type (2016-2021) 4.1.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021) 4.1.2 Global Hereditary Angioedema Revenue Market Share by Type (2016-2021) 4.1.3 Global Hereditary Angioedema Price by Type (2016-2021) 4.2 Global Hereditary Angioedema Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Hereditary Angioedema Sales Forecast by Type (2022-2027) 4.2.2 Global Hereditary Angioedema Revenue Forecast by Type (2022-2027) 4.2.3 Global Hereditary Angioedema Price Forecast by Type (2022-2027) 5 Global Hereditary Angioedema Market Size by Application 5.1 Global Hereditary Angioedema Historic Market Review by Application (2016-2021) 5.1.1 Global Hereditary Angioedema Sales Market Share by Application (2016-2021) 5.1.2 Global Hereditary Angioedema Revenue Market Share by Application (2016-2021) 5.1.3 Global Hereditary Angioedema Price by Application (2016-2021) 5.2 Global Hereditary Angioedema Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Hereditary Angioedema Sales Forecast by Application (2022-2027) 5.2.2 Global Hereditary Angioedema Revenue Forecast by Application (2022-2027) 5.2.3 Global Hereditary Angioedema Price Forecast by Application (2022-2027) 6 North America Hereditary Angioedema Market Facts & Figures 6.1 North America Hereditary Angioedema Sales by Company 6.1.1 North America Hereditary Angioedema Sales by Company (2016-2021) 6.1.2 North America Hereditary Angioedema Revenue by Company (2016-2021) 6.2 North America Hereditary Angioedema Sales Breakdown by Type 6.2.1 North America Hereditary Angioedema Sales Breakdown by Type (2016-2021) 6.2.2 North America Hereditary Angioedema Sales Breakdown by Type (2022-2027) 6.3 North America Hereditary Angioedema Sales Breakdown by Application 6.3.1 North America Hereditary Angioedema Sales Breakdown by Application (2016-2021) 6.3.2 North America Hereditary Angioedema Sales Breakdown by Application (2022-2027) 7 Europe Hereditary Angioedema Market Facts & Figures 7.1 Europe Hereditary Angioedema Sales by Company 7.1.1 Europe Hereditary Angioedema Sales by Company (2016-2021) 7.1.2 Europe Hereditary Angioedema Revenue by Company (2016-2021) 7.2 Europe Hereditary Angioedema Sales Breakdown by Type 7.2.1 Europe Hereditary Angioedema Sales Breakdown by Type (2016-2021) 7.2.2 Europe Hereditary Angioedema Sales Breakdown by Type (2022-2027) 7.3 Europe Hereditary Angioedema Sales Breakdown by Application 7.3.1 Europe 118 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 118 Sales Breakdown by Application (2022-2027) 8 China Hereditary Angioedema Market Facts & Figures 8.1 China Hereditary Angioedema Sales by Company 8.1.1 China Hereditary Angioedema Sales by Company (2016-2021) 8.1.2 China Hereditary Angioedema Revenue by Company (2016-2021) 8.2 China Hereditary Angioedema Sales Breakdown by Type 8.2.1 China Hereditary Angioedema Sales Breakdown by Type (2016-2021) 8.2.2 China Hereditary Angioedema Sales Breakdown by Type (2022-2027) 8.3 China Hereditary Angioedema Sales Breakdown by Application 8.3.1 China 145 Sales Breakdown by Application (2016-2021) 8.3.2 China 145 Sales Breakdown by Application (2022-2027) 9 Japan Hereditary Angioedema Market Facts & Figures 9.1 Japan Hereditary Angioedema Sales by Company 9.1.1 Japan Hereditary Angioedema Sales by Company (2016-2021) 9.1.2 Japan Hereditary Angioedema Revenue by Company (2016-2021) 9.2 Japan Hereditary Angioedema Sales Breakdown by Type 9.2.1 Japan Hereditary Angioedema Sales Breakdown by Type (2016-2021) 9.2.2 Japan Hereditary Angioedema Sales Breakdown by Type (2022-2027) 9.3 Japan Hereditary Angioedema Sales Breakdown by Application 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Hereditary Angioedema Market Facts & Figures 10.1 Southeast Asia Hereditary Angioedema Sales by Company 10.1.1 Southeast Asia Hereditary Angioedema Sales by Company (2016-2021) 10.1.2 Southeast Asia Hereditary Angioedema Revenue by Company (2016-2021) 10.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type 10.2.1 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Hereditary Angioedema Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Hereditary Angioedema Sales Breakdown by Application 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027) 11 India Hereditary Angioedema Market Facts & Figures 11.1 India Hereditary Angioedema Sales by Company 11.1.1 India Hereditary Angioedema Sales by Company (2016-2021) 11.1.2 India Hereditary Angioedema Revenue by Company (2016-2021) 11.2 India Hereditary Angioedema Sales Breakdown by Type 11.2.1 India Hereditary Angioedema Sales Breakdown by Type (2016-2021) 11.2.2 India Hereditary Angioedema Sales Breakdown by Type (2022-2027) 11.3 India Hereditary Angioedema Sales Breakdown by Application 11.3.1 India Hereditary Angioedema Sales Breakdown by Application (2016-2021) 11.3.2 India Hereditary Angioedema Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Hereditary Angioedema Business 12.1 Pharming Group NV 12.1.1 Pharming Group NV Corporation Information 12.1.2 Pharming Group NV Business Overview 12.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Pharming Group NV Hereditary Angioedema Products Offered 12.1.5 Pharming Group NV Recent Development 12.2 Takeda 12.2.1 Takeda Corporation Information 12.2.2 Takeda Business Overview 12.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Takeda Hereditary Angioedema Products Offered 12.2.5 Takeda Recent Development 12.3 CSL Limited 12.3.1 CSL Limited Corporation Information 12.3.2 CSL Limited Business Overview 12.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.3.4 CSL Limited Hereditary Angioedema Products Offered 12.3.5 CSL Limited Recent Development 12.4 iBio Inc. 12.4.1 iBio Inc. Corporation Information 12.4.2 iBio Inc. Business Overview 12.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.4.4 iBio Inc. Hereditary Angioedema Products Offered 12.4.5 iBio Inc. Recent Development 12.5 BioCryst Pharmaceuticals, Inc. 12.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information 12.5.2 BioCryst Pharmaceuticals, Inc. Business Overview 12.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered 12.5.5 BioCryst Pharmaceuticals, Inc. Recent Development 12.6 Ionis Pharmaceuticals, Inc. 12.6.1 Ionis Pharmaceuticals, Inc. Corporation Information 12.6.2 Ionis Pharmaceuticals, Inc. Business Overview 12.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered 12.6.5 Ionis Pharmaceuticals, Inc. Recent Development ... 13 Hereditary Angioedema Manufacturing Cost Analysis 13.1 Hereditary Angioedema Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Hereditary Angioedema 13.4 Hereditary Angioedema Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Hereditary Angioedema Distributors List 14.3 Hereditary Angioedema Customers 15 Market Dynamics 15.1 Hereditary Angioedema Market Trends 15.2 Hereditary Angioedema Drivers 15.3 Hereditary Angioedema Market Challenges 15.4 Hereditary Angioedema Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com